 |
PDBsum entry 1mqy
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Antibiotic
|
 |
|
Title:
|
 |
Nmr solution structure of type-b lantibiotics mersacidin in dpc micelles
|
|
Structure:
|
 |
Lantibiotic mersacidin. Chain: a. Synonym: type-b lantibiotics mersacidin
|
|
Source:
|
 |
Bacillus sp. Hil-y85/54728. Organism_taxid: 69002. Strain: hil y-85, 54728
|
|
NMR struc:
|
 |
13 models
|
 |
|
Authors:
|
 |
S.-T.Hsu,E.Breukink,G.Bierbaum,H.-G.Sahl,B.De Kruijff,R.Kaptein, N.A.Van Nuland,A.M.Bonvin
|
Key ref:
|
 |
S.T.Hsu
et al.
(2003).
NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity.
J Biol Chem,
278,
13110-13117.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
17-Sep-02
|
Release date:
|
11-Mar-03
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P43683
(MRSA_BACSY) -
Lantibiotic mersacidin from Bacillus sp. (strain HIL-Y85/54728)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
68 a.a.
20 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
|
*
PDB and UniProt seqs differ
at 6 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
278:13110-13117
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity.
|
|
S.T.Hsu,
E.Breukink,
G.Bierbaum,
H.G.Sahl,
B.de Kruijff,
R.Kaptein,
N.A.van Nuland,
A.M.Bonvin.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Mersacidin belongs to the type B lantibiotics (lanthionine-containing
antibiotics) that contain post-translationally modified amino acids and cyclic
ring structures. It targets the cell wall precursor lipid II and thereby
inhibits cell wall synthesis. In light of the emerging antibiotics resistance
problem, the understanding of the antibacterial activity on a structural basis
provides a key to circumvent this issue. Here we present solution NMR studies of
mersacidin-lipid II interaction in dodecylphosphocholine (DPC) micelles.
Distinct solution structures of mersacidin were determined in three different
states: in water/methanol solution and in DPC micelles with and without lipid
II. The structures in various sample conditions reveal remarkable conformational
changes in which the junction between Ala-12 and Abu-13 (where Abu is
aminobutyric acid) effectively serves as the hinge for the opening and closure
of the ring structures. The DPC micelle-bound form resembles the previously
determined NMR and x-ray crystal structures of mersacidin in pure methanol but
substantially deviates from the other two states in our current report. The
structural changes delineate the large chemical shift perturbations observed
during the course of a two-step (15)N-(1)H heteronuclear single quantum
coherence titration. They also modulate the surface charge distribution of
mersacidin suggesting that electrostatics play a central role in the
mersacidin-lipid II interaction. The observed conformational adaptability of
mersacidin might be a general feature of lipid II-interacting
antibiotics/peptides.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Primary structures of mersacidin (A) and lipid II
(B). A, post-translationally modified amino acids are
highlighted in gray, and their chemical structures are depicted
below. B, GlcNAc, N-acetylglucosamine; MurNAc, N-acetylmuramic
acid.
|
 |
Figure 8.
Fig. 8. A, representative structures (closest to average)
of each structure ensemble. The Glu-17 side chain is shown in
red. The hinge residue Abu-13 is shown in green. The structures
were fitted on backbone heavy atoms of residues 13-20 (colored
blue). The remainder of the structure is shown in gray. B,
surface electrostatic potential of mersacidin in different
sample conditions calculated with MOLMOL (40). Positive and
negative potentials are colored blue and red, respectively. The
structures are in the same orientation as in A. C, 90°
rotation along the x axis of the above structures. The charge
distributions reveal the increase of charge accessibility after
the addition of lipid II in the hydrophobic DPC micelle
solution. The structure of mersacidin in DPC micelles resembles
the x-ray structure that was solved in pure methanol.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2003,
278,
13110-13117)
copyright 2003.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
T.Caetano,
J.M.Krawczyk,
E.Mösker,
R.D.Süssmuth,
and
S.Mendo
(2011).
Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli.
|
| |
Chem Biol,
18,
90.
|
 |
|
|
|
|
 |
K.Okuda,
S.Yanagihara,
T.Sugayama,
T.Zendo,
J.Nakayama,
and
K.Sonomoto
(2010).
Functional significance of the E loop, a novel motif conserved in the lantibiotic immunity ATP-binding cassette transport systems.
|
| |
J Bacteriol,
192,
2801-2808.
|
 |
|
|
|
|
 |
S.Suda,
A.Westerbeek,
P.M.O'Connor,
R.P.Ross,
C.Hill,
and
P.D.Cotter
(2010).
Effect of bioengineering lacticin 3147 lanthionine bridges on specific activity and resistance to heat and proteases.
|
| |
Chem Biol,
17,
1151-1160.
|
 |
|
|
|
|
 |
J.B.Hamburger,
A.J.Hoertz,
A.Lee,
R.J.Senturia,
D.G.McCafferty,
and
P.J.Loll
(2009).
A crystal structure of a dimer of the antibiotic ramoplanin illustrates membrane positioning and a potential Lipid II docking interface.
|
| |
Proc Natl Acad Sci U S A,
106,
13759-13764.
|
 |
|
|
|
|
 |
T.Böttiger,
T.Schneider,
B.Martínez,
H.G.Sahl,
and
I.Wiedemann
(2009).
Influence of Ca(2+) ions on the activity of lantibiotics containing a mersacidin-like lipid II binding motif.
|
| |
Appl Environ Microbiol,
75,
4427-4434.
|
 |
|
|
|
|
 |
Z.A.Waller,
S.A.Sewitz,
S.T.Hsu,
and
S.Balasubramanian
(2009).
A small molecule that disrupts G-quadruplex DNA structure and enhances gene expression.
|
| |
J Am Chem Soc,
131,
12628-12633.
|
 |
|
|
|
|
 |
F.Castiglione,
A.Lazzarini,
L.Carrano,
E.Corti,
I.Ciciliato,
L.Gastaldo,
P.Candiani,
D.Losi,
F.Marinelli,
E.Selva,
and
F.Parenti
(2008).
Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens.
|
| |
Chem Biol,
15,
22-31.
|
 |
|
|
|
|
 |
L.E.Cooper,
A.L.McClerren,
A.Chary,
and
W.A.van der Donk
(2008).
Structure-activity relationship studies of the two-component lantibiotic haloduracin.
|
| |
Chem Biol,
15,
1035-1045.
|
 |
|
|
|
|
 |
A.Dufour,
T.Hindré,
D.Haras,
and
J.P.Le Pennec
(2007).
The biology of lantibiotics from the lacticin 481 group is coming of age.
|
| |
FEMS Microbiol Rev,
31,
134-167.
|
 |
|
|
|
|
 |
A.L.Lomize,
I.D.Pogozheva,
M.A.Lomize,
and
H.I.Mosberg
(2007).
The role of hydrophobic interactions in positioning of peripheral proteins in membranes.
|
| |
BMC Struct Biol,
7,
44.
|
 |
|
|
|
|
 |
E.B.O'Connor,
P.D.Cotter,
P.O'Connor,
O.O'Sullivan,
J.R.Tagg,
R.P.Ross,
and
C.Hill
(2007).
Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity.
|
| |
BMC Microbiol,
7,
24.
|
 |
|
|
|
|
 |
J.M.Willey,
and
W.A.van der Donk
(2007).
Lantibiotics: peptides of diverse structure and function.
|
| |
Annu Rev Microbiol,
61,
477-501.
|
 |
|
|
|
|
 |
N.I.Martin,
and
E.Breukink
(2007).
Expanding role of lipid II as a target for lantibiotics.
|
| |
Future Microbiol,
2,
513-525.
|
 |
|
|
|
|
 |
R.S.Narayan,
and
M.S.Vannieuwenhze
(2007).
Synthesis of Substrates and Biochemical Probes for Study of the Peptidoglycan Biosynthetic Pathway.
|
| |
European J Org Chem,
2007,
1399-1414.
|
 |
|
|
|
|
 |
A.L.McClerren,
L.E.Cooper,
C.Quan,
P.M.Thomas,
N.L.Kelleher,
and
W.A.van der Donk
(2006).
Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic.
|
| |
Proc Natl Acad Sci U S A,
103,
17243-17248.
|
 |
|
|
|
|
 |
E.Breukink,
and
B.de Kruijff
(2006).
Lipid II as a target for antibiotics.
|
| |
Nat Rev Drug Discov,
5,
321-332.
|
 |
|
|
|
|
 |
I.Holtsmark,
D.Mantzilas,
V.G.Eijsink,
and
M.B.Brurberg
(2006).
Purification, characterization, and gene sequence of michiganin A, an actagardine-like lantibiotic produced by the tomato pathogen Clavibacter michiganensis subsp. michiganensis.
|
| |
Appl Environ Microbiol,
72,
5814-5821.
|
 |
|
|
|
|
 |
I.Wiedemann,
T.Böttiger,
R.R.Bonelli,
A.Wiese,
S.O.Hagge,
T.Gutsmann,
U.Seydel,
L.Deegan,
C.Hill,
P.Ross,
and
H.G.Sahl
(2006).
The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II.
|
| |
Mol Microbiol,
61,
285-296.
|
 |
|
|
|
|
 |
I.Wiedemann,
T.Böttiger,
R.R.Bonelli,
T.Schneider,
H.G.Sahl,
and
B.Martínez
(2006).
Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.
|
| |
Appl Environ Microbiol,
72,
2809-2814.
|
 |
|
|
|
|
 |
J.Nagao,
S.M.Asaduzzaman,
Y.Aso,
K.Okuda,
J.Nakayama,
and
K.Sonomoto
(2006).
Lantibiotics: insight and foresight for new paradigm.
|
| |
J Biosci Bioeng,
102,
139-149.
|
 |
|
|
|
|
 |
J.S.Grinstead,
S.T.Hsu,
W.Laan,
A.M.Bonvin,
K.J.Hellingwerf,
R.Boelens,
and
R.Kaptein
(2006).
The solution structure of the AppA BLUF domain: insight into the mechanism of light-induced signaling.
|
| |
Chembiochem,
7,
187-193.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.D.Cotter,
L.H.Deegan,
E.M.Lawton,
L.A.Draper,
P.M.O'Connor,
C.Hill,
and
R.P.Ross
(2006).
Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design.
|
| |
Mol Microbiol,
62,
735-747.
|
 |
|
|
|
|
 |
S.M.Asaduzzaman,
J.Nagao,
Y.Aso,
J.Nakayama,
and
K.Sonomoto
(2006).
Lysine-oriented charges trigger the membrane binding and activity of nukacin ISK-1.
|
| |
Appl Environ Microbiol,
72,
6012-6017.
|
 |
|
|
|
|
 |
G.C.Patton,
and
W.A.van der Donk
(2005).
New developments in lantibiotic biosynthesis and mode of action.
|
| |
Curr Opin Microbiol,
8,
543-551.
|
 |
|
|
|
|
 |
H.He
(2005).
Mannopeptimycins, a novel class of glycopeptide antibiotics active against gram-positive bacteria.
|
| |
Appl Microbiol Biotechnol,
67,
444-452.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |